Evidence map›Paper›PMID 39241207›Full record

ArticleJCO oncology practice2025

Patient, Parent, and Oncologist Perspectives and Recommendations on the Right Way to Talk About Prognosis in Advanced Childhood Cancer.

Erica C Kaye, Harmony Farner, Shoshana Mehler, Kelly Bien, Nidhi Mali, Tara M Brinkman, Justin N Baker, Pamela Hinds, Jennifer W Mack

Abstract read
In one paragraph

Article in JCO oncology practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Journal of psychosocial oncology · 2026
    Article
  7. Article
  8. Article
  9. Understanding theChildren (Basel, Switzerland) · 2025
    Article
  10. "I had no idea what to expect": adolescent and young adults with cancer identify opportunities for patient-centered anticipatory guidance through narrative writing.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Erica C KayeDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-6522-3876
Harmony FarnerDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN.
Shoshana MehlerDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-9854-6305
Kelly BienDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN.
Nidhi MaliDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN.
Tara M BrinkmanDepartment of Psychology and Biobehavioral Sciences, St Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-4250-6160
Justin N BakerDepartment of Pediatrics, Stanford University, Palo Alto, CA.
Pamela HindsDepartment of Nursing Science, Professional Practice & Quality, Children's National Hospital, Washington, DC.ORCID 0000-0001-6491-6649
Jennifer W MackDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0001-5791-4178

Funding

IMPROVING PROGNOSTIC COMMUNICATION IN PEDIATRIC CANCERK08CA266935 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Erica Carmen Kaye · 2022 to 2026
$1.0M
NCI NIH HHS K08 CA266935
6 · The paper itself

Abstract

purposeClear prognostic communication is associated with improvements in quality of life and suffering for children with advanced illness. Yet recent evidence demonstrates that pediatric oncologists often avoid, defer, or soften prognostic disclosure. We aimed to describe pediatric cancer shareholder perspectives on quality prognostic communication to inform design of an intervention to improve prognostic disclosure in advanced childhood cancer.

methodsSemi-structured interviews were conducted with a purposeful sample of pediatric patients with cancer (n = 20), parents (n = 20), and oncologists (n = 20) representing six institutions across five states. Rapid analysis was performed using the National Cancer Institute core communication functions to organize domains of inquiry.

resultsThree main themes were endorsed by participants regarding the ideal timing of prognostic disclosure: early, ongoing, individualized. Although each group emphasized the need for an individualized approach, oncologists rarely elicited patient/parent preferences for prognostic communication and more commonly inferred what a patient/family wanted to hear. Participants described five key pillars for how to facilitate quality prognostic disclosure: conversation leadership, overall attendance, patient inclusion, location, and atmosphere. They also identified four themes around ideal prognostic content: range of information, use of numbers, population-level versus patient-specific information, and tone/delivery. Discordant recommendations between patients/parents and oncologists emerged for how much and what information to share.

conclusionPediatric cancer shareholders advocated for diverse, and sometimes conflicting, approaches for prognostic disclosure. Although nearly all participants endorsed the importance of individualized prognostic disclosure, specific strategies to encourage or facilitate person-centered prognostic conversation are lacking. Future research will focus on collaboration with pediatric patients, parents, and oncologists to codesign a clinical intervention to improve prognostic communication for children with advanced cancer and their families.

Indexed as

CommunicationNeoplasmsOncologistsParentsPhysician-Patient RelationsAdolescentAdultChildChild, PreschoolFemaleHumansMalePrognosisTruth Disclosure

Identifiers

PMID39241207
PMCPMC11882923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.